CXCL12 and diabetes mellitus: Transgenic mice expressing CXCL12 in their β-cells are protected against streptozotocin-induced diabetes through the activation of the pro-survival protein kinase Akt and downstream pro-survival, anti-apoptotic signaling pathways (236).